Fetuin-A regulation of calcified matrix metabolism

Circulation Research

Volumn 108, Issue 12, 2011, Pages 1494-1509

  Jahnen Dechent, Willi ^a   Heiss, Alexander ^a   Schäfer, Cora ^a   Ketteler, Markus ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b KLINIKUM COBURG   (Germany)

Author keywords

calcification; mineral metabolism; plasma proteins

Indexed keywords

ALBUMIN; CALCIUM; FETUIN A; PHOSPHATE; PLASMA PROTEIN;

ARTICLE; BONE DEVELOPMENT; CALCIFICATION; CALCIUM METABOLISM; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION;

ANIMALS; BLOOD PROTEINS; CALCINOSIS; CALCIUM; HUMANS; MICE; OSTEOGENESIS; PHOSPHATES; PROTEIN BINDING;

EID: 79958779779     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.110.234260     Document Type: Article

References (180)

1. Pedersen KO. Fetuin, a new globulin isolated from serum. Nature. 1944;154:575.
2. Heremans JF. Les Globulines Sériques du Système Gamma. Brussels: Arscia, 1960.
3. Schmid K, Bürgi W. Preparation and properties of the human plasma Ba-alpha2-glycoproteins. Biochim Biophys Acta. 1961;47:440-453.
4. Schultze HE, Heide K, Haupt H. Charakterisierung eines niedermolekularen a2-Mukoids aus Humanserum. Naturwiss. 1962;49:15-17.
5. Heiss A, DuChesne A, Denecke B, Grötzinger J, Yamamoto K, Renné T, Jahnen-Dechent W. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem. 2003;278:13333-13341. (Pubitemid 36800105)
6. Jahnen-Dechent W, Trindl A, Godovac-Zimmermann J, Müller-Esterl W. Posttranslational processing of human alpha 2-HS glycoprotein (human fetuin). Evidence for the production of a phosphorylated single-chain form by hepatoma cells. Eur J Biochem. 1994;226:59-69. (Pubitemid 24348669)
7. Nawratil P, Lenzen S, Kellermann J, Haupt H, Schinke T, Müller-Esterl W, Jahnen-Dechent W. Limited proteolysis of human alpha2-HS glycoprotein/ fetuin. Evidence that a chymotryptic activity can release the connecting peptide. J Biol Chem. 1996;271:31735-31741. (Pubitemid 26408641)
8. Edge AS, Spiro RG. Presence of an O-glycosidically linked hexasaccharide in fetuin. J Biol Chem. 1987;262:16135-16141.
9. Bendiak B, Harris-Brandts M, Michnick SW, Carver JP, Cumming DA. Separation of the complex asparagine-linked oligosaccharides of the glycoprotein fetuin and elucidation of three triantennary structures having sialic acids linked only to galactose residues. Biochemistry. 1989;28:6491-6499. (Pubitemid 19202042)
10. Denecke B, Gräber S, Schäfer C, Heiss A, Wöltje M, Jahnen-Dechent W. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J. 2003;376: 135-145. (Pubitemid 37487209)
11. Ohnishi T, Nakamura O, Arakaki N, Miyazaki H, Daikuhara Y. Effects of cytokines and growth factors on phosphorylated fetuin biosynthesis by adult rat hepatocytes in primary culture. Biochem Biophys Res Comm. 1994;200:598-605. (Pubitemid 24183649)
12. Ohnishi T, Nakamura O, Arakaki N, Daikuhara Y. Effect of phosphorylated rat fetuin on the growth of hepatocytes in primary culture in the presence of human hepatocyte-growth factor. Evidence that phosphorylated fetuin is a natural modulator of hepatocyte-growth factor. Eur J Biochem. 1997;243:753-761. (Pubitemid 27073445)
13. Haglund AC, Ek B, Ek P. Phosphorylation of human plasma alpha2- Heremans-Schmid glycoprotein (human fetuin) in vivo. Biochem J. 2001;357:437-445. (Pubitemid 32701780)
14. Memoli B, De Bartolo L, Favia P, Morelli S, Lopez LC, Procino A, Barbieri G, Curcio E, Giorno L, Esposito P, Cozzolino M, Brancaccio D, Andreucci VE, d'Agostino R, Drioli E. Fetuin - A gene expression, synthesis and release in primary human hepatocytes cultured in a galactosylated membrane bioreactor. Biomaterials. 2007;28:4836-4844.
15. Kübler D, Gosenca D, Wind M, Heid H, Friedberg I, Jahnen-Dechent W, Lehmann WD. Proteolytic processing by matrix metalloproteinases and phosphorylation by protein kinase CK2 of fetuin-A, the major globulin of fetal calf serum. Biochimie. 2007;89:410-418. (Pubitemid 46442762)
16. Hortin GL, Schilling M, Graham JP. Inhibitors of the sulfation of proteins, glycoproteins, and proteoglycans. Biochem Biophys Res Comm. 1988;150:342-348. (Pubitemid 18036241)
17. Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, Rossi B, Le Cam A. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell. 1989;58:631-640. (Pubitemid 19210957)
18. Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS, Grunberger G. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol. 2000;164:87-98. (Pubitemid 30665503)
19. Schinke T, Amendt C, Trindl A, Pöschke O, Müller-Esterl W, Jahnen- Dechent W. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem. 1996;271: 20789-20796. (Pubitemid 26281865)
20. Berg T, Ose T, Ose L, Tolleshaug H. Intracellular degradation of 125I-labelled asialo-glycoproteins in rat hepatocytes: effect of leupeptin on subcellular distribution of asialo-fetuin. Int J Biochem. 1981;13: 253-259. (Pubitemid 11149451)
21. Lodish HF. Recognition of complex oligosaccharides by the multisubunit asialoglycoprotein receptor. Trends Biochem Sci. 1991;16: 374-377. (Pubitemid 121004476)
22. Spiess M. The asialoglycoprotein receptor: a model for endocytic transport receptors. Biochemistry. 1990;29:10009-10018. (Pubitemid 20365657)
23. Nie Z. Fetuin: its enigmatic property of growth promotion. Am J Physiol. 1992;263:C551-C562.
24. Hinkle P. Efraim Racker, 1913-1991. J Bioenerg Biomembr. 1992;24: 517-519.
25. Kornberg A. Ten commandments: lessons from the enzymology of DNA replication. J Bacteriol. 2000;182:3613-3618. (Pubitemid 30413008)
26. Olivier E, Soury E, Ruminy P, Husson A, Parmentier F, Daveau M, Salier JP. Fetuin-B, a second member of the fetuin family in mammals. Biochem J. 2000;350:589-597.
27. Jethwaney D, Lepore T, Hassan S, Mello K, Rangarajan R, Jahnen- Dechent W, Wirth D, Sultan AA. Fetuin-A, a hepatocyte-specific protein that binds Plasmodium berghei thrombospondin-related adhesive protein: a potential role in infectivity. Infect Immun. 2005;73: 5883-5891. (Pubitemid 41193025)
28. Fisher H, Puck T, Sato G. Molecular growth requirements of single mammalian cells: the action of fetuin in promoting cell attachment to glass. Proc Natl Acad Sci USA. 1958;44:4-10.
29. Tajirian T, Dennis JW, Swallow CJ. Regulation of human monocyte proMMP-9 production by fetuin, an endogenous TGF-beta antagonist. J Cell Physiol. 2000;185:174-183.
30. Leite-Browning ML, McCawley LJ, Choi OH, Matrisian LM, Ochieng J. Interactions of alpha2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells. Int J Oncol. 2002;21:965-971.
31. Hedrich J, Lottaz D, Meyer K, Yiallouros I, Jahnen-Dechent W, Stöcker W, Becker-Pauly C. Fetuin-A and cystatin C are endogenous inhibitors of human meprin metalloproteases. Biochemistry. 2010;49:8599-8607.
32. Mellgren RL, Huang X. Fetuin A stabilizes m-calpain and facilitates plasma membrane repair. J Biol Chem. 2007;282:35868-35877. (Pubitemid 350277142)
33. Nakamura O, Kazi JA, Ohnishi T, Arakaki N, Shao Q, Kajihara T, Daikuhara Y. Effects of rat fetuin on stimulation of bone resorption in the presence of parathyroid hormone. Biosci Biotechnol Biochem. 1999; 63:1383-1391. (Pubitemid 129549150)
34. Kundranda MN, Henderson M, Carter KJ, Gorden L, Binhazim A, Ray S, Baptiste T, Shokrani M, Leite-Browning ML, Jahnen-Dechent W, Matrisian LM, Ochieng J. The serum glycoprotein fetuin-A promotes Lewis lung carcinoma tumorigenesis via adhesive-dependent and adhesive-independent mechanisms. Cancer Res. 2005;65:499-506.
35. Leite-Browning ML, McCawley LJ, Jahnen-Dechent W, King L Jr, Matrisian L, Ochieng J. Alpha 2-HS glycoprotein (fetuin-A) modulates murine skin tumorigenesis. Int J Oncol. 2004;25:319-324.
36. Kumbla L, Bhadra S, Subbiah MT. Multifunctional role for fetuin (fetal protein) in lipid transport. FASEB J. 1991;5:2971-2975. (Pubitemid 21905839)
37. Cayatte AJ, Kumbla L, Subbiah MT. Marked acceleration of exogenous fatty acid incorporation into cellular triglycerides by fetuin. J Biol Chem. 1990;265:5883-5888.
38. Kumbla L, Cayatte AJ, Subbiah MT. Association of a lipoprotein-like particle with bovine fetuin. FASEB J. 1989;3:2075-2080. (Pubitemid 19187617)
39. Dasgupta S, Bhattacharya S, Biswas A, Majumdar SS, Mukhopadhyay S, Ray S, Bhattacharya S. NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochem J. 2010;429:451-462.
40. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008;7:489-503. (Pubitemid 351767117)
41. Skelton SK, Wong KH. Simple, efficient purification of filamentous hemagglutinin and pertussis toxin from Bordetella pertussis by hydrophobic and affinity interaction. J Clin Microbiol. 1990;28:1062-1065. (Pubitemid 20141228)
42. Chong P, Klein M. Single-step purification of pertussis toxin and its subunits by heat-treated fetuin-sepharose affinity chromatography. Biochem Cell Biol. 1989;67:387-391. (Pubitemid 19220482)
43. Grossbard ML, Lambert JM, Goldmacher VS, Blättler WA, Nadler LM. Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin. Cancer Res. 1992;52: 4200-4207.
44. Cawley DB, Simpson DL, Herschman HR. Asialoglycoprotein receptor mediates the toxic effects of an asialofetuin-diphtheria toxin fragment A conjugate on cultured rat hepatocytes. Proc Natl Acad Sci USA. 1981; 78:3383-3387. (Pubitemid 11059294)
45. Demetriou M, Binkert C, Sukhu B, Tenenbaum HC, Dennis JW. Fetuin/ alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J Biol Chem. 1996;271: 12755-12761. (Pubitemid 26175845)
46. Binkert C, Demetriou M, Sukhu B, Szweras M, Tenenbaum HC, Dennis JW. Regulation of osteogenesis by fetuin. J Biol Chem. 1999;274: 28514-28520.
47. Szweras M, Liu D, Partridge EA, Pawling J, Sukhu B, Clokie C, Jahnen-Dechent W, Tenenbaum HC, Swallow CJ, Grynpas MD, Dennis JW. alpha 2-HS glycoprotein/fetuin, a transforming growth factorbeta/ bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem. 2002;277:19991-19997. (Pubitemid 34967522)
48. Swallow CJ, Partridge EA, Macmillan JC, Tajirian T, DiGuglielmo GM, Hay K, Szweras M, Jahnen-Dechent W, Wrana JL, Redston M, Gallinger S, Dennis JW. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression. Cancer Res. 2004;64:6402-6409. (Pubitemid 39297893)
49. Zhang M, Caragine T, Wang H, Cohen PS, Botchkina G, Soda K, Bianchi M, Ulrich P, Cerami A, Sherry B, Tracey KJ. Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J Exp Med. 1997;185:1759-1768. (Pubitemid 27242197)
50. Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ. Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. Proc Natl Acad Sci USA. 1998;95:14429-14434.
51. Wang H, Zhang M, Soda K, Sama A, Tracey K. Fetuin protects the fetus from TNF. Lancet. 1997;350:861-862.
52. Dziegielewska KM, Andersen NA. The fetal glycoprotein, fetuin, counteracts ill-effects of the bacterial endotoxin, lipopolysaccharide, in pregnancy. Biol Neonate. 1998;74:372-375. (Pubitemid 28461755)
53. Ombrellino M, Wang H, Yang H, Zhang M, Vishnubhakat J, Frazier A, Scher LA, Friedman SG, Tracey KJ. Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock. 2001;15:181-185. (Pubitemid 33599100)
54. Wang H, Li W, Zhu S, Li J, D'Amore J, Ward MF, Yang H, Wu R, Jahnen-Dechent W, Tracey KJ, Wang P, Sama AE. Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats. J Cereb Blood Flow Metab. 2010;30:493-504.
55. Li W, Zhu S, Li J, Huang Y, Rongrong, Zhou, Fan X, Yang H, Gong X, Eissa NT, Jahnen-Dechent W, Wang P, Tracey KJ, Sama AE, Wang H. A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation. PLoS One. 2011:1-31.
56. Chertov OYu, Ermolaeva MV, Satpaev DK, Saschenko LP, Kabanova OD, Lukanidin EM, Lukjianova TI, Redchenko IV, Blishchenko LY, Gnuchev NV. Inhibitory effect of calf fetuin on the cytotoxic activity of LAK cell-derived factors and tumor necrosis factor. Immunol Lett. 1994;42:97-100. (Pubitemid 24305202)
57. Terkeltaub RA, Santoro DA, Mandel G, Mandel N. Serum and plasma inhibit neutrophil stimulation by hydroxyapatite crystals. Evidence that serum alpha 2-HS glycoprotein is a potent and specific crystal-bound inhibitor. Arthritis Rheum. 1988;31:1081-1089.
58. Pazár B, Ea HK, Narayan S, Kolly L, Bagnoud N, Chobaz V, Roger T, Lioté F, So A, Busso N. Basic calcium phosphate crystals induce monocyte/macrophage IL-1 secretion through the NLRP3 inflammasome in vitro. J Immunol. 2011;186:2495-2502.
59. Nadra I, Boccaccini AR, Philippidis P, Whelan LC, McCarthy GM, Haskard DO, Landis RC. Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages. Atherosclerosis. 2008;196:98-105.
60. Nadra I, Mason JC, Philippidis P, Florey O, Smythe CD, McCarthy GM, Landis RC, Haskard DO. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ Res. 2005;96:1248-1256. (Pubitemid 40962102)
61. Ewence AE, Bootman M, Roderick HL, Skepper JN, McCarthy G, Epple M, Neumann M, Shanahan CM, Proudfoot D. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res. 2008;103:28-34.
62. Ea HK, Uzan B, Rey C, Lioté F. Octacalcium phosphate crystals directly stimulate expression of inducible nitric oxide synthase through p38 and JNK mitogen-activated protein kinases in articular chondrocytes. Arthritis Res Ther. 2005;7:R915-926.
63. Halverson PB, Derfus BA. Calcium crystal-induced inflammation. Curr Opin Rheumatol. 2001;13:221-224. (Pubitemid 32430076)
64. Halverson PB, Greene A, Cheung HS. Intracellular calcium responses to basic calcium phosphate crystals in fibroblasts. Osteoarth Cartilage. 1998;6:324-329. (Pubitemid 28404973)
65. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, Jahnen-Dechent W, Shanahan CM. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol. 2005;16:2920-2930. (Pubitemid 44743490)
66. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000;192:565-570. (Pubitemid 30666257)
67. Zhang M, Borovikova LV, Wang H, Metz C, Tracey KJ. Spermine inhibition of monocyte activation and inflammation. Mol Med. 1999;5: 595-605. (Pubitemid 32936950)
68. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248-251. (Pubitemid 29329996)
69. Shanahan CM. Inflammation ushers in calcification: a cycle of damage and protection? Circulation. 2007;116:2782-2785. (Pubitemid 350291219)
70. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation. 2006;113:1760-1767. (Pubitemid 43958469)
71. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Häring HU, Boeing H, Fritsche A. Plasma fetuin - a levels and the risk of myocardial infarction and ischemic stroke. Circulation. 2008;118: 2555-2562.
72. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Häring HU, Schulze MB. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes. 2008;57:2762-2767.
73. Fisher E, Stefan N, Saar K, Drogan D, Schulze MB, Fritsche A, Joost HG, Häring HU, Hubner N, Boeing H, Weikert C. Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study. Circ Cardiovasc Genet. 2009;2: 607-613.
74. Rauth G, Pöschke O, Fink E, Eulitz M, Tippmer S, Kellerer M, Häring HU, Nawratil P, Haasemann M, Jahnen-Dechent W. The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor. Eur J Biochem. 1992;204:523-529.
75. Le Cam A, Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, Rossi B. pp63 is very likely the rat fetuin. Cell. 1992;68:8.
76. Brown WM, Christie DL, Dziegielewska KM, Saunders NR, Yang F. The rat protein encoded by clone pp63 is a fetuin/alpha 2-HS glycoprotein- like molecule, but is it the tyrosine kinase inhibitor pp63? Cell. 1992;68:7-8.
77. Chen H, Srinivas PR, Cong LN, Li Y, Grunberger G, Quon MJ. Alpha2- Heremans Schmid glycoprotein inhibits insulin-stimulated Elk-1 phosphorylation, but not glucose transport, in rat adipose cells. Endocrinology. 1998;139:4147-4154. (Pubitemid 28513700)
78. Mathews ST, Srinivas PR, Leon MA, Grunberger G. Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase. Life Sci. 1997;61: 1583-1592. (Pubitemid 27425275)
79. Mathews ST, Rakhade S, Zhou X, Parker GC, Coscina DV, Grunberger G. Fetuin-null mice are protected against obesity and insulin resistance associated with aging. Biochem Biophys Res Comm. 2006;350:437-443. (Pubitemid 44498655)
80. Jahnen-Dechent W, Schinke T, Trindl A, Müller-Esterl W, Sablitzky F, Kaiser S, Blessing M. Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem. 1997;272:31496-31503. (Pubitemid 28013290)
81. Wong N, Blair AR, Morahan G, Andrikopoulos S. The deletion variant of nicotinamide nucleotide transhydrogenase (Nnt) does not affect insulin secretion or glucose tolerance. Endocrinology. 2010;151: 96-102.
82. Laboratory TJ. The Nnt deletion in C57BL/6J mice-questions and answers. Jackson Laboratory Newsletter. 2009:1-2.
83. Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, Jen KL, Charron MJ, Jahnen-Dechent W, Grunberger G. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes. 2002;51:2450-2458. (Pubitemid 34827393)
84. Falquerho L, Paquereau L, Vilarem MJ, Galas S, Patey G, Le Cam A. Functional characterization of the promoter of pp63, a gene encoding a natural inhibitor of the insulin receptor tyrosine kinase. Nucleic Acids Res. 1992;20:1983-1990.
85. Daveau M, Christian-Davrinche, Julen N, Hiron M, Arnaud P, Lebreton JP. The synthesis of human alpha-2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells. FEBS Lett. 1988;241:191-194. (Pubitemid 19005004)
86. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest. 1979;64:1118-1129. (Pubitemid 10232592)
87. Metry G, Stenvinkel P, Qureshi AR, Carrero JJ, Yilmaz MI, Bárány P, Snaedal S, Heimbürger O, Lindholm B, Suliman ME. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients. Eur J Clin Invest. 2008;38:804-811.
88. Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant. 2005; 20:1676-1685. (Pubitemid 41418594)
89. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 2003;361:827-833. (Pubitemid 36331846)
90. Ogawa W, Kasuga M. Cell signaling. Fat stress and liver resistance. Science. 2008;322:1483-1484.
91. Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, Häring H-U, Stefan N. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE. 2008;3:e1765.
92. Schinke T, Koide T, Jahnen-Dechent W. Human histidine-rich glycoprotein expressed in SF9 insect cells inhibits apatite formation. FEBS Lett. 1997;412:559-562. (Pubitemid 27337109)
93. Herwald H, Jahnen-Dechent W, Alla SA, Hock J, Bouma BN, Müller- Esterl W. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain. J Biol Chem. 1993;268: 14527-14535. (Pubitemid 23195585)
94. Brown WM, Dziegielewska KM, Saunders NR, Christie DL, Nawratil P, Müller-Esterl W. The nucleotide and deduced amino acid structures of sheep and pig fetuin. Common structural features of the mammalian fetuin family. Eur J Biochem. 1992;205:321-331.
95. Hock J, Vogel R, Linke RP, Müller-Esterl W. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies. J Biol Chem. 1990;265:12005-12011.
96. Kellermann J, Haupt H, Auerswald E, Müller-Ester W. The arrangement of disulfide loops in human alpha 2-HS glycoprotein. Similarity to the disulfide bridge structures of cystatins and kininogens. J Biol Chem. 1989;264:14121-14128. (Pubitemid 19214240)
97. White H, Totty N, Panayotou G. Haemonectin, a granulocytic-cellbinding protein, is related to the plasma glycoprotein fetuin. Eur J Biochem. 1993;213:523-528. (Pubitemid 23106086)
98. Triffitt JT, Owen ME, Ashton BA, Wilson JM. Plasma disappearance of rabbit alpha2HS-glycoprotein and its uptake by bone tissue. Calcif Tissue Res. 1978;26:155-161.
99. Triffitt JT, Gebauer U, Ashton BA, Owen ME, Reynolds JJ. Origin of plasma alpha2HS-glycoprotein and its accumulation in bone. Nature. 1976;262:226-227.
100. Triffitt JT. Plasma proteins present in human cortical bone: enrichment of the alpha2HS-glycoprotein. Calcif Tissue Res. 1976;22:27-33.
101. Dickson IR, Poole AR, Veis A. Localisation of plasma alpha2HS glycoprotein in mineralising human bone. Nature. 1975;256:430-432.
102. Termine JD, Belcourt AB, Conn KM, Kleinman HK. Mineral and collagen-binding proteins of fetal calf bone. J Biol Chem. 1981;256: 10403-10408. (Pubitemid 12219434)
103. Schäfer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, M̈uller-Esterl W, Schinke T, Jahnen-Dechent W. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112: 357-366. (Pubitemid 38063764)
104. Jahnen-Dechent W, Schäfer C, Ketteler M, McKee MD. Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med. 2008;86:379-389.
105. Westenfeld R, Schäfer C, Krüger T, Haarmann C, Schurgers LJ, Reutelingsperger C, Ivanovski O, Drueke T, Massy ZA, Ketteler M, Floege J, Jahnen-Dechent W. Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol. 2009;20:1264-1274.
106. Westenfeld R, Schäfer C, Smeets R, Brandenburg VM, Floege J, Ketteler M, Jahnen-Dechent W. Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant. 2007;22:1537-1546. (Pubitemid 47073751)
107. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol. 2004;15:2857-2867. (Pubitemid 41103395)
108. Olde Loohuis KM, Jahnen-Dechent W, van Dorp W. The case: milky ascites is not always chylous. Kidney Int. 2010;77:77-78.
109. Heiss A, Eckert T, Aretz A, Richtering W, van Dorp W, Schäfer C, Jahnen-Dechent W. Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J Biol Chem. 2008;283:14815-14825.
110. Wald J, Wiese S, Eckert T, Jahnen-Dechent W, Richtering W, Heiss A. Structure and stability of calcium phosphate - fetuin-A colloids probed by time-resolved dynamic light scattering. Soft Matter. 2011;7: 2869-2874.
111. Heiss A, Pipich V, Jahnen-Dechent W, Schwahn D. Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on fetuin-A controlled calcification inhibition. Biophys J. 2010; 99:3989-3995.
112. Rochette CN, Rosenfeldt S, Heiss A, Narayanan T, Ballauff M, Jahnen- Dechent W. A shielding topology stabilizes the early stage proteinmineral complexes of fetuin-A and calcium phosphate: a time-resolved small-angle X-ray study. Chembiochem. 2009;10:735-740.
113. Heiss A, Jahnen-Dechent W, Endo H, Schwahn D. Structural dynamics of a colloidal protein-mineral complex bestowing on calcium phosphate a high solubility in biological fluids. Biointerphases. 2007;2:16-20.
114. Price PA, Williamson MK, Nguyen TM, Than TN. Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem. 2004;279:1594-1600. (Pubitemid 38084423)
115. Price PA, Lim JE. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem. 2003;278:22144-22152. (Pubitemid 36792625)
116. Price PA, Nguyen TM, Williamson MK. Biochemical characterization of the serum fetuin-mineral complex. J Biol Chem. 2003;278: 22153-22160. (Pubitemid 36792626)
117. Price PA, Caputo JM, Williamson MK. Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. J Bone Miner Res. 2002;17:1171-1179. (Pubitemid 34680493)
118. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, Williamson MK. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem. 2002;277:3926-3934. (Pubitemid 34968645)
119. Ciftçiogilu N, McKay DS. Pathological calcification and replicating calcifying-nanoparticles: general approach and correlation. Pediatr Res. 2010;67:490-499.
120. Raoult D, Drancourt M, Azza S, Nappez C, Guieu R, Rolain JM, Fourquet P, Campagna B, La Scola B, Mege J-L, Mansuelle P, Lechevalier E, Berland Y, Gorvel JP, Renesto P. Nanobacteria are mineralo fetuin complexes. PLoS Pathog. 2008;4:e41.
121. Young JD, Martel J, Young L, Wu CY, Young A, Young D. Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS ONE. 2009;4:e4417.
122. Wu C-Y, Martel J, Young D, Young JD. Fetuin-a/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept. PLoS ONE. 2009;4:e8058.
123. Mahamid J, Aichmayer B, Shimoni E, Ziblat R, Li C, Siegel S, Paris O, Fratzl P, Weiner S, Addadi L. Mapping amorphous calcium phosphate transformation into crystalline mineral from the cell to the bone in zebrafish fin rays. Proc Natl Acad Sci USA. 2010;107:6316-6321.
124. Wang L, Nancollas GH. Pathways to biomineralization and biodemineralization of calcium phosphates: the thermodynamic and kinetic controls. Dalton Transactions. 2009;2665-2672.
125. Nudelman F, Pieterse K, George A, Bomans PH, Friedrich H, Brylka LJ, Hilbers PA, de With G, Sommerdijk NA. The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors. Nat Mater. 2010;9:1004-1009.
126. Cölfen H. Biomineralization: A crystal-clear view. Nat Mater. 2010;9: 960-961.
127. Price PA, Toroian D, Lim JE. Mineralization by inhibitor exclusion: the calcification of collagen with fetuin. J Biol Chem. 2009;284: 17092-17101.
128. Toroian D, Price PA. The essential role of fetuin in the serum-induced calcification of collagen. Calcif Tissue Int. 2008;82:116-126.
129. Toroian D, Lim JE, Price PA. The size exclusion characteristics of type I collagen: implications for the role of noncollagenous bone constituents in mineralization. J Biol Chem. 2007;282:22437-22447. (Pubitemid 47267338)
130. Folk R. SEM imaging of bacteria and nannobacteria in carbonate sediments and rocks. J Sediment Res. 1993;63:990-999. (Pubitemid 24397097)
131. McKay DS, Gibson EK Jr, Thomas-Keprta KL, Vali H, Romanek CS, Clemett SJ, Chillier XD, Maechling CR, Zare RN. Search for past life on Mars: possible relic biogenic activity in martian meteorite ALH84001. Science. 1996;273:924-930.
132. Kajander EO, Ciftçioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci USA. 1998;95:8274-8279. (Pubitemid 28326103)
133. Ciftçioglu N, Björklund M, Kuorikoski K, Bergström K, Kajander EO. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int. 1999;56:1893-1898. (Pubitemid 29518191)
134. Sedivy R, Battistutti WB. Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS. 2003;111:951-954. (Pubitemid 37352613)
135. Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, Jones ML, Caughey RC, Brown R, Millikin PD, Darras FS. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int. 2000;57: 2360-2374. (Pubitemid 30340735)
136. Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, Rasmussen TE, Yagubyan M, Rodgers JC, Cockerill FR, Folk RL, Rzewuska-Lech E, Kumar V, Farell-Baril G, Lieske JC. Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol. 2004;287:1115-1124.
137. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, Kopecko DJ. An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci USA. 2000;97:11511-11515.
138. Young JD, Martel J. The rise and fall of nanobacteria. Sci Am. 2010; 302:52-59.
139. Martel J, Young JD. Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc Natl Acad Sci USA. 2008;105: 5549-5554. (Pubitemid 351753900)
140. Young JD, Martel J, Young D, Young A, Hung CM, Young L, Chao YJ, Young J, Wu CY. Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria. PLoS ONE. 2009;4:e5421.
141. Matsui I, Hamano T, Mikami S, Fujii N, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Rakugi H, Imai E, Isaka Y. Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenineinduced renal failure. Kidney Int. 2009;75:915-928.
142. Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol JASN. 2010;21:1998 -2007.
143. van Oss CJ, Gillman CF, Bronson PM, Border JR. Opsonic properties of human serum alpha-2 hs glycoprotein. Immunol Commun. 1974;3: 329-335.
144. Lewis JG, André CM. Effect of human alpha 2HS glycoprotein on mouse macrophage function. Immunology. 1980;39:317-322. (Pubitemid 10120775)
145. Lewis JG, André CM. Enhancement of human monocyte phagocytic
146. Thiele L, Diederichs JE, Reszka R, Merkle HP, Walter E. Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells. Biomaterials. 2003;24:1409-1418. (Pubitemid 36069107)
147. Jersmann HP, Dransfield I, Hart SP. Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci. 2003;105:273-278. (Pubitemid 37088565)
148. Moghimi SM, Hunter AC. Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. Pharm Res. 2001;18:1-8. (Pubitemid 32299615)
149. Andrade JD, Hlady V. Plasma protein adsorption: the big twelve. Ann N Y Acad Sci. 1987;516:158-172.
150. Trinkle-Mulcahy L, Boulon S, Lam YW, Urcia R, Boisvert FM, Vandermoere F, Morrice NA, Swift S, Rothbauer U, Leonhardt H, Lamond A. Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. J Cell Biol. 2008;183: 223-239.
151. Wajih N, Borras T, Xue W, Hutson SM, Wallin R. Processing and transport of matrix gamma-carboxyglutamic acid protein and bone morphogenetic protein-2 in cultured human vascular smooth muscle cells: evidence for an uptake mechanism for serum fetuin. J Biol Chem. 2004;279:43052-43060. (Pubitemid 39372200)
152. Neven E, D'Haese PC. Vascular calcification in chronic renal failure: what have we learned from animal studies? Circ Res. 2011;108: 249-264.
153. van den Broek FA, Beynen AC. The influence of dietary phosphorus and magnesium concentrations on the calcium content of heart and kidneys of DBA/2 and NMRI mice. Lab Anim. 1998;32:483-491. (Pubitemid 28482484)
154. van den Broek FA, Bakker R, den Bieman M, Fielmich-Bouwman AX, Lemmens AG, van Lith HA, Nissen I, Ritskes-Hoitinga JM, van Tintelen G, van Zutphen LF. Genetic analysis of dystrophic cardiac calcification in DBA/2 mice. Biochem Biophys Res Comm. 1998;253: 204-208. (Pubitemid 29026682)
155. Brunnert SR. Morphologic response of myocardium to freeze-thaw injury in mouse strains with dystrophic cardiac calcification. Lab Anim Sci. 1997;47:11-18.
156. Merx MW, Schäfer C, Westenfeld R, Brandenburg V, Hidajat S, Weber C, Ketteler M, Jahnen-Dechent W. Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-Adeficient mice. J Am Soc Nephrol. 2005;16:3357-3364. (Pubitemid 46179339)
157. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386:78-81. (Pubitemid 27130923)
158. Meng H, Vera I, Che N, Wang X, Wang SS, Ingram-Drake L, Schadt EE, Drake TA, Lusis AJ. Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc Natl Acad Sci USA. 2007;104:4530-4535. (Pubitemid 47186259)
159. Jiang Q, Dibra F, Lee MD, Oldenburg R, Uitto J. Overexpression of fetuin - a counteracts ectopic mineralization in a mouse model of pseudoxanthoma elasticum (abcc6(-/-)). J Invest Dermatol. 2010;130: 1288-1296.
160. Umulis D, O'Connor MB, Blair SS. The extracellular regulation of bone morphogenetic protein signaling. Development. 2009;136:3715-3728.
161. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millán JL. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol. 2004;164:1199-1209. (Pubitemid 38387787)
162. Neven E, Persy V, Dauwe S, De Schutter T, De Broe ME, D'Haese PC. Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats. Arterioscler Thromb Vasc Biol. 2010;30:1741-1750.
163. Murshed M, McKee MD. Molecular determinants of extracellular matrix mineralization in bone and blood vessels. Curr Opin Nephrol Hypertension. 2010;19:359-365.
164. Speer MY, Yang HY, Brabb T, Leaf E, Look A, Lin WL, Frutkin A, Dichek D, Giachelli CM. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res. 2009;104:733-741.
165. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38:938-942. (Pubitemid 34258697)
166. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007;71:438-441.
167. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol JASN. 2003;14: 159-168. (Pubitemid 36032720)
168. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int. 2005;67:1216-1233. (Pubitemid 40463099)
169. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimbürger O, Holmes C, Schalling M, Nordfors L. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int. 2005;67:2383-2392. (Pubitemid 41623401)
170. Moe SM, Reslerova M, Ketteler M, O'neill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int. 2005;67:2295-2304. (Pubitemid 41623389)
171. Koos R, Brandenburg V, Mahnken AH, Mühlenbruch G, Stanzel S, Günther RW, Floege J, Jahnen-Dechent W, Kelm M, Kühl HP. Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients. Eur Heart J. 2009;30:2054-2061.
172. Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, Shlipak MG, Whooley MA, Ix JH. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med. 2010;152:640-648.
173. Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, Takasu J, Gupta A, Norris K, Ketteler M, Adler S. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int. 2005;67:1070-1077. (Pubitemid 41623332)
174. Brandenburg VM, Cozzolino M, Ketteler M. Calciphylaxis: a still unmet challenge. J Nephrol. 2011;24:142-148.
175. Schlieper G, Brandenburg V, Ketteler M, Floege J. Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol. 2009;5:539-543.
176. Bode W, Engh R, Musil D, Thiele U, Huber R, Karshikov A, Brzin J, Kos J, Turk V. The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 1988;7:2593-2599.
177. Serre L, Verbree EC, Dauter Z, Stuitje AR, Derewenda ZS. The Escherichia coli malonyl-CoA:acyl carrier protein transacylase at 1.5-A resolution. Crystal structure of a fatty acid synthase component. J Biol Chem. 1995;270:12961-12964.
178. Momma K, Izumi F. VESTA: a three-dimensional visualization system for electronic and structural analysis. J Applied Crystallography. 2008; 41:653-658. (Pubitemid 351693898)
179. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14:33-38. (Pubitemid 26152973)
180. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA. 2001;98:10037-10041. (Pubitemid 32802969)